PUBLISHER: GlobalData | PRODUCT CODE: 1535184
PUBLISHER: GlobalData | PRODUCT CODE: 1535184
Corneal Implants Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Ophthalmic Devices therapeutic area.
A Corneal Implant is a naturally based or artificially engineered cornea that is implanted onto an eye of a patient to replace his or her damaged or diseased cornea.
Corneal blindness severely impacts quality of life among people. Adults with corneal blindness often have lower rates of workforce participation and productivity. Population growth and ageing are expected to increase the risk that more people acquire corneal blindness. Corneal transplantation is a surgical procedure that involves the replacement of a part of cornea with a donor corneal tissue (corneal graft) or a keratoprosthesis (KPro, also known as an artificial cornea). Keratoconus a condition which occurs when cornea thins and bulges out causing blurred vision and sensitivity to light. Intrastromal corneal ring segments (ICRS) are made of PMMA (Polymethylmethacrylate) and are placed in the deep, peripheral corneal stroma to flatten the cornea and thus treat Keratoconus.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Corneal Implants and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Sightlife, CorneagGen Inc, AJL Ophthalmic SA, Massachusetts Eye and Ear Infirmary, Lions VisionGift, Keramed Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -